The IGF2 protein has a tumour-promoting effect on existing colorectal neoplasia (7–10) and that LOI of IGF2 in either tissue or peripheral blood leukocyte (PBL) samples is associated with an increased risk of CRC (11, 12). This evidence concerns the gene IGF2 and neoplasm.